AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteYK 4-279 is an inhibitor of RNA Helicase A (RHA) binding to the oncogenic transciption factor EWS-FLI1.
More Information Supplier PageYK 4-279 is an inhibitor of RNA Helicase A (RHA) binding to the oncogenic transciption factor EWS-FLI1.
More Information Supplier PageYK 4-279 is an inhibitor of RNA Helicase A (RHA) binding to the oncogenic transciption factor EWS-FLI1.
More Information Supplier PageYK 4-279 is an inhibitor of RNA Helicase A (RHA) binding to the oncogenic transciption factor EWS-FLI1.
More Information Supplier PageYL-109 has ability to inhibit breast cancer cell growth and invasiveness in vitro and in vivo.
More Information Supplier PageYL-109 has ability to inhibit breast cancer cell growth and invasiveness in vitro and in vivo.
More Information Supplier PageYL-109 has ability to inhibit breast cancer cell growth and invasiveness in vitro and in vivo.
More Information Supplier PageYM-155 is a potent survivin suppressant by inhibiting Survivin promoter activity with IC50 of 0.54 nM.
More Information Supplier PageYM-155 is a potent survivin suppressant by inhibiting Survivin promoter activity with IC50 of 0.54 nM.
More Information Supplier PageYM-155 is a potent survivin suppressant by inhibiting Survivin promoter activity with IC50 of 0.54 nM.
More Information Supplier PageYM-53601 is a novel squalene synthase inhibitor. It suppresses lipogenic biosynthesis and lipid secretion in rodents.
More Information Supplier PageYM-53601 is a novel squalene synthase inhibitor. It suppresses lipogenic biosynthesis and lipid secretion in rodents.
More Information Supplier PageYM-53601 is a novel squalene synthase inhibitor. It suppresses lipogenic biosynthesis and lipid secretion in rodents.
More Information Supplier PageYM155 is a novel small molecule survivin suppressant with an IC50 of 0.54 nM for the inhibition of survivin promoter activity.
More Information Supplier PageYM155 is a novel small molecule survivin suppressant with an IC50 of 0.54 nM for the inhibition of survivin promoter activity.
More Information Supplier PageYM155 is a novel small molecule survivin suppressant with an IC50 of 0.54 nM for the inhibition of survivin promoter activity.
More Information Supplier PageYM155 is a novel small molecule survivin suppressant with an IC50 of 0.54 nM for the inhibition of survivin promoter activity.
More Information Supplier PageYM155 is a novel small molecule survivin suppressant with an IC50 of 0.54 nM for the inhibition of survivin promoter activity.
More Information Supplier PageYM201636 is a cell-permeable and selective inhibitor of PIKfyve (IC50 = 33 nM).
More Information Supplier PageYM201636 is a cell-permeable and selective inhibitor of PIKfyve (IC50 = 33 nM).
More Information Supplier PageYM201636 is a cell-permeable and selective inhibitor of PIKfyve (IC50 = 33 nM).
More Information Supplier PageYM201636 is a cell-permeable and selective inhibitor of PIKfyve (IC50 = 33 nM).
More Information Supplier PageYM201636 is a cell-permeable and selective inhibitor of PIKfyve (IC50 = 33 nM).
More Information Supplier PageYM90K hydrochloride is a selective AMPA receptor antagonist that delays neuronal death in a global ischemia model and cerebral infarction in a focal ischemia model following postischemic administration.
More Information Supplier PageYM90K hydrochloride is a selective AMPA receptor antagonist that delays neuronal death in a global ischemia model and cerebral infarction in a focal ischemia model following postischemic administration.
More Information Supplier PageYM90K hydrochloride is a selective AMPA receptor antagonist that delays neuronal death in a global ischemia model and cerebral infarction in a focal ischemia model following postischemic administration.
More Information Supplier PageYO-01027 is a dipeptidic γ-secretase inhibitor, an antiAlzheimer agent.
More Information Supplier PageYO-01027 is a dipeptidic γ-secretase inhibitor, an antiAlzheimer agent.
More Information Supplier PageYO-01027 is a dipeptidic γ-secretase inhibitor, an antiAlzheimer agent.
More Information Supplier PageYO-01027 is a dipeptidic γ-secretase inhibitor, an antiAlzheimer agent.
More Information Supplier PageYO-01027 is a dipeptidic γ-secretase inhibitor, an antiAlzheimer agent.
More Information Supplier PageYohimbine hydrochloride (Antagonil) is a ??2-adrenoceptor antagonist (pKi values are 8.52, 8.00 and 9.17 for human ??2A, ??2B and ??2C receptors respectively)
More Information Supplier PageYohimbine hydrochloride (Antagonil) is a ??2-adrenoceptor antagonist (pKi values are 8.52, 8.00 and 9.17 for human ??2A, ??2B and ??2C receptors respectively)
More Information Supplier PageYunaconitine, extracted from Ranunculaceae Aconitum in southern Yunnan roots.
More Information Supplier PageYunaconitine, extracted from Ranunculaceae Aconitum in southern Yunnan roots.
More Information Supplier PageYunaconitine, extracted from Ranunculaceae Aconitum in southern Yunnan roots.
More Information Supplier PageZ-360 is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity.
More Information Supplier PageZ-360 is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity.
More Information Supplier Page
